Ultralife Co. (NASDAQ:ULBI – Get Free Report) Director W. Shaw Robert bought 2,500 shares of the stock in a transaction on Tuesday, November 12th. The shares were acquired at an average cost of $7.91 per share, for a total transaction of $19,775.00. Following the purchase, the director now owns 65,250 shares in the company, valued at $516,127.50. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Ultralife Trading Up 0.6 %
Shares of ULBI stock traded up $0.05 during mid-day trading on Tuesday, reaching $8.00. The company’s stock had a trading volume of 96,755 shares, compared to its average volume of 80,204. The firm has a market capitalization of $132.98 million, a PE ratio of 14.45 and a beta of 0.98. The company has a quick ratio of 2.06, a current ratio of 4.07 and a debt-to-equity ratio of 0.07. Ultralife Co. has a 12-month low of $6.36 and a 12-month high of $13.39. The company’s 50 day simple moving average is $9.12 and its 200-day simple moving average is $10.34.
Hedge Funds Weigh In On Ultralife
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Connor Clark & Lunn Investment Management Ltd. raised its stake in Ultralife by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 157,330 shares of the technology company’s stock valued at $1,422,000 after purchasing an additional 21,140 shares during the period. Janney Montgomery Scott LLC grew its position in Ultralife by 2.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 443,150 shares of the technology company’s stock worth $4,006,000 after purchasing an additional 10,450 shares during the last quarter. Juncture Wealth Strategies LLC acquired a new position in shares of Ultralife in the third quarter valued at $165,000. XTX Topco Ltd boosted its stake in Ultralife by 192.1% in the 2nd quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock valued at $397,000 after buying an additional 24,595 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in Ultralife by 9.1% in the 2nd quarter. Renaissance Technologies LLC now owns 242,490 shares of the technology company’s stock valued at $2,575,000 after purchasing an additional 20,300 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on ULBI
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
- Five stocks we like better than Ultralife
- How to Use the MarketBeat Stock Screener
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is a Death Cross in Stocks?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Why Are Stock Sectors Important to Successful Investing?
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.